{{Rsnum
|rsid=571715
|Gene=PRKCQ
|Chromosome=10
|position=6556554
|Orientation=plus
|GMAF=0.2695
|Gene_s=PRKCQ
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=135
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 2.7 | 32.1 | 65.2
| HCB | 15.3 | 43.1 | 41.6
| JPT | 10.6 | 39.8 | 49.6
| YRI | 19.7 | 47.6 | 32.7
| ASW | 12.3 | 40.4 | 47.4
| CHB | 15.3 | 43.1 | 41.6
| CHD | 15.6 | 35.8 | 48.6
| GIH | 14.9 | 43.6 | 41.6
| LWK | 10.9 | 53.6 | 35.5
| MEX | 1.7 | 34.5 | 63.8
| MKK | 21.8 | 43.6 | 34.6
| TSI | 6.9 | 23.5 | 69.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=22546513
|Title=Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}